Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Laryngoscope. 2020 Jan 6;130(12):E773–E781. doi: 10.1002/lary.28493

Fig. 5.

Fig. 5.

BPTES reduces the glycolytic reserve in iLTS scar fibroblasts at 24 hours. (A) Glycolytic test conducted on an XF24 analyzer of a patient set. There is no significant difference in glycolysis capacity (B) and maximal respiration (C) between BPTES treated and untreated iLTS scar fibroblasts. (D) BPTES treated iLTS scar fibroblasts show significant lower glycolytic reserve that untreated iLTS scar fibroblasts. *P < .01. 2-DG = 2-deoxy-glucose; BPTES = bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl) ethyl sulfide; ECAR = extracellular acidification rate; iLTS = iatrogenic laryngotracheal stenosis.